MARLBOROUGH, Mass.,
(May 3, 2021 /PRNewswire/
-- Boston Scientific Corporation (NYSE: BSX) will participate
in two upcoming investor conferences.
On May 11, 2021, Dan Brennan, executive vice president and chief
financial officer, and Susie Lisa,
vice president, Investor Relations, will participate in a 35-minute
question-and-answer session with the host analyst at the virtual
2021 Bank of America Health Care Conference. The session will begin
at approximately 9:30 a.m. EDT.
On May 25, 2021, Jeff Mirviss, executive vice president and
president, Peripheral Interventions; Peter
Pattison, president, Interventional Oncology, Peripheral
Interventions; Cat Jennings, vice president, marketing and new
business development, Peripheral Interventions; and Susie Lisa will participate in a 45-minute
question-and-answer session with the host analyst at the 2021 UBS
Global Healthcare Virtual Conference. The session will begin at
approximately 9 a.m. EDT.
A live webcast and replay of the webcast for each event will be
accessible at investors.bostonscientific.com. The replay will
be available beginning approximately one hour following the
completion of each event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for 40 years, we advance science for life by providing a
broad range of high performance solutions that address unmet
patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
|
|
Media:
|
Investors:
|
Katie
Schur
|
Susie Lisa,
CFA
|
508-683-5574
(office)
|
508-683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
Katie.Schur@bsci.com
|
BSXInvestorRelations@bsci.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/boston-scientific-announces-may-conference-schedule-301281924.html
SOURCE Boston Scientific Corporation